Atlas Trials

Anthracycline-induced Cardiotoxicity

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Anthracycline-induced Cardiotoxicity

RecordFirmDate
Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity (NCT07572175)Icahn School of Medicine at Mount Sinai2026-07-01
Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy (NCT07528586)Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)2026-03-04
Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial (NCT07442578)Dana-Farber Cancer Institute2026-03-04
Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients (NCT07254221)Shiraz University of Medical Sciences2026-02-01
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors (NCT04852965)Queen's University, Belfast2021-10-20
Preventing Cardiac Sequelae in Pediatric Cancer Survivors (NCT01805778)The Hospital for Sick Children2012-12-01
Spironolactone Against Anthracycline-induced Cardiomyopathy (NCT02053974)TC Erciyes University2011-09-01

Track Anthracycline-induced Cardiotoxicity automatically

Every clearance here is in the API, with alerts when new ones post.